Merck Global Health Innovation Fund contributed to a series B round that boosted the drone-based delivery service's total funding to $75m.
US-based drone delivery service Volansi completed a $50m series B round on Tuesday that included Merck Global Health Innovation Fund, the corporate venturing arm of pharmaceutical firm Merck & Co.
Venture capital firm Icon Ventures led the round, which was also backed by Lightspeed Venture Partners, Y Combinator and Harpoon Ventures. The company said it had raised $25m before closing the round.
Volansi offers on-demand delivery services using vertical take-off and landing drones, enabling customers to send items over long…
